Identification of Ovarian Cancer Using in Silico-Based Analysis of the Downregulated Expressed miRNAs

levels using small RNAs molecules including microRNAs. These molecules have played a key role in the growth of malignant tumour of ovary including cellular proliferation and metastasis. We carried out a meta-analysis of previously published miRNA expression datasets (two human datasets GSE83693 and GSE119055) and one mouse GSE98391 to identify the downregulated miRNA and its target genes with biological processes and pathways. Meta-analysis of miRNA datasets showed that miR-378a-3p, miR-378a -5p and miR-378c are commonly downregulated miRNAs among the three databases in cancerous samples in comparison to normal samples. A total of 405 common gene targets for miR-378a-3p, -5p and miR-378c were identified using miRWALK. Enrichment analysis revealed that miRNAs target genes were predominantly linked to protein binding as well as in Ras signalling pathways. In addition, multiple hub miRNA target genes in the PPI network provided poor prognosis for the patients with OC including FLT1, its level was closely relevant to ovarian cancer. Overall, these investigations exhibited that the defined miRNAs and their target genes could be exploited as biomarkers to identify ovarian malignancies and achieve an early effective therapy.

• Publication year

  2023

• Venue

  Egyptian Academic Journal of Biological Sciences C Physiology and Molecular Biology

• Publication date

  2023-09-23

• Fields of study

  Not labeled

• Identifiers
  DOI 10.21608/eajbsc.2023.317702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Expression of miR-589-5p, miR-569 and c-Fos gene in Oral Squamous Cell Carcinoma

  2022cited by this paper
• MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs

  2022cited by this paper
• miR-378c suppresses Wilms tumor development via negatively regulating CAMKK2.

  2021cited by this paper
• Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer

  2021cited by this paper
• Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer

  2021cited by this paper
• Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10)

  2021cited by this paper
• miR-1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer

  2020cited by this paper
• MicroRNA-378-3p/5p suppresses migration and invasion of oral squamous carcinoma cells by inhibiting KLK4 expression.

  2020cited by this paper
• RNA Binding

  2020cited by this paper
• Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research

  2020cited by this paper
• MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients.

  2019cited by this paper
• Ovarian Cancer Animal Models for Preclinical Studies and Development of Ovarian Cancer Drugs

  2019cited by this paper
• The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy

  2019cited by this paper
• Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer

  2019cited by this paper
• MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities

  2019cited by this paper
• Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells

  2018cited by this paper
• miRWalk: An online resource for prediction of microRNA binding sites

  2018cited by this paper
• Low-grade Serous Ovarian Carcinoma

  2018cited by this paper
• The Adequate Corpus Luteum: miR-96 Promotes Luteal Cell Survival and Progesterone Production

  2017cited by this paper
• 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression

  2017influential reference
• Global trends and predictions in ovarian cancer mortality.

  2016cited by this paper
• Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue

  2016cited by this paper
• MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF

  2015cited by this paper
• cytoHubba: identifying hub objects and sub-networks from complex interactome

  2014cited by this paper
• Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.

  2014cited by this paper
• Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implications.

  2014cited by this paper
• Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women

  2014cited by this paper
• Characterization of microRNAs differentially expressed during bovine follicle development.

  2014cited by this paper
• Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

  2014cited by this paper
• Consequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly.

  2012cited by this paper
• Epithelial ovarian cancer.

  2012cited by this paper
• Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

  2011cited by this paper
• Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas

  2010cited by this paper
• MicroRNA Expression Profiles in Serous Ovarian Carcinoma

  2008cited by this paper
• DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis

  2007cited by this paper
• Gonadotropins and ovarian cancer.

  2007cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• IDENTIFICATION OF NOVEL

  1964cited by this paper

• Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool.

  2024cites this paper